Live Feed

Delayed 3m

Buys · SEC · Leadership Updates

Signed out · 3-min delay · Sign up for real-time

PR22:31:00·4h·Technology·
$MDRX
Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director
Veradigm® India Private Limited, the India subsidiary of Veradigm (OTC:MDRX), a US-based leader in clinical and revenue cycle solutions for independent practices, today announced a major expansion of its Pune operations, doubling its office capacity and adding a new managing director. This milestone marks a significant chapter in Veradigm's growth journey, reflecting the company's continued investment in its people, its infrastructure, and its long-term vision for India. Located in one of Pune's prime business districts, the expansion is designed to support scale, inspire collaboration, and create an environment where teams can do their best work. It is a direct expression of Veradigm's f
INSIDER21:56:16·5h·Consumer Discretionary·
$GAME
See Footnote (1) Blue & Silver Ventures, Ltd. bought $1,324,436 worth of shares (2,234,364 units at $0.59), increasing direct ownership by 137% to 3,861,736 units (SEC Form 4)
4 - GameSquare Holdings, Inc. (0001714562) (Issuer)
SEC21:30:18·5h·Technology·
$MSGM
Amendment: SEC Form SCHEDULE 13D/A filed by Motorsport Games Inc.
SCHEDULE 13D/A - Motorsport Games Inc. (0001821175) (Subject)
INSIDER20:00:12·7h·Industrials·
$CLIR
Director Silva Gil Todd bought $10,569 worth of shares (2,000 units at $5.28), increasing direct ownership by 50% to 6,000 units (SEC Form 4)
4 - ClearSign Technologies Corp (0001434524) (Issuer)
SEC19:26:18·8h·Health Care·
$ACRS
Amendment: SEC Form SCHEDULE 13G/A filed by Aclaris Therapeutics Inc.
SCHEDULE 13G/A - Aclaris Therapeutics, Inc. (0001557746) (Subject)
SEC19:22:11·8h·Finance·
$STEP
Amendment: SEC Form SCHEDULE 13G/A filed by StepStone Group Inc.
SCHEDULE 13G/A - StepStone Group Inc. (0001796022) (Subject)
SEC19:14:08·8h·Health Care·
$IMDX
Amendment: SEC Form SCHEDULE 13D/A filed by Insight Molecular Diagnostics Inc.
SCHEDULE 13D/A - Insight Molecular Diagnostics Inc. (0001642380) (Subject)
INSIDER19:08:17·8h·Health Care·
$IMDX
Large owner Broadwood Partners, L.P. bought $2,032,251 worth of shares (570,184 units at $3.56) (SEC Form 4)
4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
INSIDER18:34:52·8h·Industrials·
$GGG
Director Simon Andrea Helen bought $99,857 worth of shares (1,240 units at $80.53) (SEC Form 4)
4 - GRACO INC (0000042888) (Issuer)
PR18:15:00·9h·Consumer Discretionary·
$GDEN $SPGI $VICI
LifeStance Health Group Set to Join S&P SmallCap 600
NEW YORK, April 27, 2026 /PRNewswire/ -- LifeStance Health Group Inc. (NASD: LFST) will replace Golden Entertainment Inc (NASD: GDEN) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, May 1. S&P 500 constituent VICI Properties Inc. (NYSE:VICI) and Blake Sartini are acquiring Golden Entertainment in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name ActionCompany NameTickerGICS SectorMay 1, 2026S&P SmallCap 600AdditionLifeStance Health GroupLFSTHealth CareMay 1, 2026S&P SmallCap 600DeletionGolden EntertainmentGDENConsum
SEC18:05:29·9h·Finance·
$GAVA
SEC Form 144 filed by Grayscale Avalanche Staking ETF
144 - Grayscale Avalanche Staking ETF (0002035053) (Subject)
PR18:04:59·9h·Consumer Discretionary·
$GSL
Global Ship Lease Announces Annual Meeting of Shareholders
ATHENS, Greece, April 27, 2026 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (the "Company") has scheduled its Annual Meeting of Shareholders for June 17, 2026, at 10:00 a.m. Eastern Time (the "Annual Meeting"). The record date for determining shareholders entitled to participate at the Annual Meeting is April 20, 2026. The business of the Annual Meeting is to (i) elect three Term III Directors to serve until the 2029 Annual Meeting of Shareholders, (ii) ratify the appointment of PricewaterhouseCoopers S.A., as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, and (iii) to approve the Company's Second Amended and Restated Art
SEC18:00:24·9h·Finance·
$ECAT
Amendment: SEC Form SCHEDULE 13D/A filed by BlackRock ESG Capital Allocation Term Trust
SCHEDULE 13D/A - BlackRock ESG Capital Allocation Term Trust (0001864843) (Subject)
SEC17:53:04·9h·Finance·
$BLK
SEC Form 144 filed by BlackRock Inc.
144 - BlackRock, Inc. (0002012383) (Subject)
INSIDER17:50:19·9h·Consumer Discretionary·
$MHH
Large owner Shaw Steven A bought $7,040 worth of shares (1,000 units at $7.04) (SEC Form 4)
4 - Mastech Digital, Inc. (0001437226) (Issuer)
INSIDER17:34:47·9h·Health Care·
$ABT
EVP AND CFO Boudreau Philip P bought $201,300 worth of Common shares without par value (2,200 units at $91.50) (SEC Form 4)
4 - ABBOTT LABORATORIES (0000001800) (Issuer)
INSIDER17:33:08·9h·Health Care·
$HEPA
Director Purcell Michael J. bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)
4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
SEC17:30:45·9h·Health Care·
$RVMD
SEC Form DEF 14A filed by Revolution Medicines Inc.
DEF 14A - Revolution Medicines, Inc. (0001628171) (Filer)
SEC17:30:43·9h·Finance·
$CORZ
Core Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Core Scientific, Inc./tx (0001839341) (Filer)
SEC17:29:23·9h·Consumer Discretionary·
$UP
Wheels Up Experience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Other Events, Financial Statements and Exhibits
8-K - Wheels Up Experience Inc. (0001819516) (Filer)